RBSH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RBSH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Rebus Hldgs's Book Value per Share for the quarter that ended in Jun. 2023 was $-0.18.
During the past 3 years, the average Book Value per Share Growth Rate was 94.60% per year. During the past 5 years, the average Book Value per Share Growth Rate was 93.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Rebus Hldgs was 95.70% per year. The lowest was 94.60% per year. And the median was 95.20% per year.
For the Biotechnology subindustry, Rebus Hldgs's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Rebus Hldgs's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Rebus Hldgs's 3-Year Book Growth Rate falls into.
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
Rebus Hldgs (OTCPK:RBSH) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Thank you for viewing the detailed overview of Rebus Hldgs's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
John Robison Montgomery | director | 7647 BIRCHWOOD HILL RD, CROZET VA 22932 |
Richard E Buller | director | C/O CELCUITY INC., 16305 36TH AVE. N., #100, MINNEAPOLIS MN 55446 |
Claire Thom | director | 31200 VIA COLINAS, #200, WESTLAKE VILLAGE CA 91362 |
Ronald L Shazer | officer: Chief Medical Officer | C/O TRACON PHARMACEUTICALS, INC., 8910 UNIVERSITY CENTER LANE, STE 700, SAN DIEGO CA 92122 |
Christopher P. Lowe | director, officer: President and CEO | 2511 N LOOP 1604,, SUITE 204, SAN ANTONIO TX 78258 |
Scott Varde Ogilvie | director | 10880 WILSHIRE BLVD, SUITE 950, LOS ANGELES CA 90024 |
Bo Jesper Hansen | director | BIRKENWEG 16, MEGGEN V8 6045 |
Peter E Grebow | director | 41 MOORES ROAD, FRAZER PA 19355 |
Craig A Dionne | director, 10 percent owner, officer: CEO,CFO, President | 9901 IH 10 WEST, SUITE 800, SAN ANTONIO TX 78230 |
Russell Richerson | 10 percent owner, officer: COO, Secretary | 2511 N LOOP 1604 W, SUITE 204, SAN ANTONIO TX 78258 |
Kihong Kwon | 10 percent owner | 1015 E. CHAPMAN AVE, SUITE 201, FULLERTON CA 92831 |
From GuruFocus
By ACCESSWIRE ACCESSWIRE • 10-09-2020
By ACCESSWIRE ACCESSWIRE • 01-12-2021
By ACCESSWIRE ACCESSWIRE • 12-10-2020
By ACCESSWIRE ACCESSWIRE • 02-18-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.